Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
GLP-1 drugs, although FDA-approved for obesity, would require new clinical trials and approvals (likely beginning with Phase I and II) to be used for treating addiction
Water, L-carnitine 20%, acid (citric acid), inulin, flavouring, nicotinamide, preservatives (sorbic acid, sodium benzoate), D-pantothenate, calcium, green tea (Camellia sinensis) leaf extract 0.05%, pyridoxine hydrochloride, sweeteners (acesulfame K, sucralose), thiamin hydrochloride, colours (Azorubine1, Brilliant Blue FCF)
Liraglutide shows similar effects, but with shorter receptor engagement due to lower molecular stability